Premier Fund Managers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
23,652
-12,352
-34% -$6.93M 1.15% 34
2026
Q1
$20.1M Buy
36,004
+4,967
+16% +$3.19M 1.42% 28
2025
Q4
$21.2M Sell
31,037
-52,065
-63% -$35.5M 1.22% 36
2025
Q3
$52.4M Sell
83,102
-63,026
-43% -$38.3M 2.15% 10
2025
Q2
$77.6M Buy
146,128
+115,351
+375% +$55.2M 2.83% 5
2025
Q1
$12.8M Buy
+30,777
New +$13.4M 0.48% 51

Other funds holding IDXX

Premier Fund Managers's IDXX Position: Q2 2026 in Review

Premier Fund Managers reduced its Idexx Laboratories (IDXX) stake by 34% in Q2 2026, selling an estimated $6.93M and leaving 23,652 shares worth $12.7M. The position accounts for 1.15% of the portfolio, ranked #34.

Premier Fund Managers first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $77.6M in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Premier Fund Managers held 23,652 shares of Idexx Laboratories worth $12.7M as of Q2 2026.
  • Premier Fund Managers sold 12,352 Idexx Laboratories shares in Q2 2026, an estimated $6.93M.
  • Idexx Laboratories made up 1.15% of Premier Fund Managers's portfolio in Q2 2026, its #34 holding.
  • Premier Fund Managers first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Premier Fund Managers's Idexx Laboratories position peaked at $77.6M in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Premier Fund Managers's 13F filing for Q2 2026, filed 22 Jul 2026.